Yager's Liniment Recalled for Manufacturing Practice Violations
Ecometics recalls Yager's Liniment due to manufacturing practice violations affecting products nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for CGMP deviations with no reported illnesses. A drug product not manufactured under current good manufacturing practices constitutes a risk-of-harm product where injury has not yet been reported, per the severity rubric.
Plain-English summary
Ecometics, Inc. is recalling Yager's Liniment (containing 3.1% Camphor and 8.12% Turpentine Oil) in 4 FL OZ and 8 FL OZ bottles nationwide. The affected lot is 0E267A. Approximately 5,028 units of the 4 oz bottles (UPC 0 11169 00004 6) and 9,809 units of the 8 oz bottles (UPC 0 11169 00008 4) are involved in this recall.
The U.S. Food and Drug Administration determined that the product was not manufactured under current good manufacturing practices (CGMP). This means the manufacturer did not follow required quality standards during production.
Consumers who have purchased Yager's Liniment with lot 0E267A should stop using the product immediately. Return unused portions to the place of purchase or contact Ecometics, Inc. with questions. Consumers with health concerns should consult their healthcare provider.
The recalled product
- Product
- YAGER'S LINIMENT (Camphor and Turpentine Oil) 3.1% and 8.12% respectively, packaged in a) 4 FL OZ (118 mL) bottles, UPC 0 11169 00004 6, and 8 FL OZ (236 mL) bottles, UPC 0 11169 00008 4, The Oakhurst Co., Dist., Levittown, NY 11756.
- Manufacturer
- Ecometics, Inc.
- Category
- Drug — Topical Liniment
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 0E267A
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27